Healthcare is catching the rotation out of AI. Josh Brown's list includes two names that can benefit
Healthcare sector is gaining momentum as investors rotate out of AI stocks. Analysts highlight Waters Corp. (WAT) and Thermo Fisher Scientific (TMO) as key players in life science tools. WAT reported Q2 earnings with revenue of $1.65B and EPS of $3.05, raising full-year guidance. TMO reported Q2 revenue of $11.99B and EPS of $6.03, with multiple analysts raising price targets. Both companies are set to report Q3 earnings soon.
How this was made
The 30-second read
Why it matters
Both companies delivered better‑than‑expected Q2 results and raised guidance, reinforcing a bullish view on the healthcare tools niche.
Market read
While the earnings data are not new, the article underscores a sector shift toward healthcare, which may influence short‑term allocation decisions.
What to watch
Potential supply‑chain constraints for lab instruments and regulatory scrutiny on biotech tools.
Background
The article is a commentary piece highlighting recent earnings beats and guidance upgrades for two life‑science equipment makers, positioning healthcare as a sector rotation target.
Ticker impact
Waters reported Q2 earnings with revenue and EPS beats and raised full-year organic growth guidance to 7%-9% and EPS to $14.45-$14.65.
likely upward pressure as investors price in higher growth expectations.
Guidance lift and beat are fresh compared to prior quarters, but the numbers were disclosed earlier; the article is a recap.
Thermo Fisher posted Q2 results beating estimates and lifted full-year revenue guidance to $47.4B-$48.1B and EPS to $24.93-$25.33.
likely upward pressure as the market digests the upgraded outlook.
Guidance increase is material, but the earnings were already released; the article adds commentary only.
Market effects
Healthcare sector outperformance may attract rotation from AI‑heavy tech stocks.
U.S. market focus on healthcare tools could boost related stocks.
Limited to U.S. investors; no direct global macro effect.
Counterpoint
The recent run‑up may have priced in most of the upside; a pullback could test support levels.
Key entities
- companyWaters Corp.
Provider of analytical instruments and consumables for life‑science labs.
- companyThermo Fisher Scientific
Largest global supplier of life‑science tools and services.
